Welcome, Guest. Please login or register.
November 28, 2021, 09:52:11 pm

Login with username, password and session length

 

Members
Stats
  • Total Posts: 327
  • Total Topics: 183
  • Online Today: 32
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 9
Total: 9

Welcome!

Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Study Hints at New Immune Therapy Target in Triple-Negative Breast Cancer  (Read 1632 times)

Offline Cancer Health Editors

  • Jr. Member
  • **
  • Posts: 56
    • View Profile
Therapies that recruit the immune system to attack tumors are revolutionizing cancer care. Among these successful immunotherapies is a class known as “checkpoint inhibitors” that unmask tumors’ ability to hide from the immune system.

However, checkpoint inhibitors aren’t universally successful against all cancers. A University of Colorado Cancer Center study published in the Journal of Clinical Investigation unpacks the actions taken by an especially dangerous cancer type — triple-negative breast cancer — to initiate the process that eventually allows the cancer to become invisible to the immune system.

By defining the roots of immune system evasion, researchers hope to develop therapies that could augment those currently in use, making the immune system an even more powerful partner in combatting cancer.

Read more...
https://www.cancerhealth.com/article/study-hints-new-immune-therapy-target-triplenegative-breast-cancer

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.